Metacrine, Inc.
MTCR · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $28 | $74 | $226 | $224 |
| - Cash | $76 | $96 | $16 | $16 |
| + Debt | $14 | $9 | $11 | $3 |
| Enterprise Value | -$34 | -$13 | $222 | $211 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | – | – | – | 100% |
| EBITDA | -$60 | -$35 | -$28 | -$25 |
| % Margin | – | – | – | -1,723.6% |
| Net Income | -$61 | -$36 | -$29 | -$26 |
| % Margin | – | – | – | -1,780.8% |
| EPS Diluted | -1.45 | -3.87 | -1.52 | -1.35 |
| % Growth | 62.5% | -154.6% | -12.6% | – |
| Operating Cash Flow | -$47 | -$36 | -$28 | -$25 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$47 | -$36 | -$28 | -$26 |